ICD-10

ICD-10 code D75.81

You are here: Home > ICD-10-CM > D50-D89 > D70-D77 > D75 > D75.8

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- D70-D77
Other disorders of blood and blood-forming organs
- D75
Other and unspecified diseases of blood and blood-forming organs
- D75.8
Other specified diseases of blood and blood-forming organs

D75.81

Myelofibrosis

ICD-10 code D75.81 for Myelofibrosis

Myelofibrosis NOS
Secondary myelofibrosis NOS
Code first the underlying disorder, such as:
malignant neoplasm of breast (C50.-)
Use additional code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
Use additional code for adverse effect, if applicable, to identify drug (T45.1X5)
Excludes1: acute myelofibrosis (C94.4-)
idiopathic myelofibrosis (D47.1)
leukoerythroblastic anemia (D61.82)
myelofibrosis with myeloid metaplasia (D47.4)
myelophthisic anemia (D61.82)
myelophthisis (D61.82)
primary myelofibrosis (D47.1)
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us